| IPAD-DB ID | C00419 |
| Name | Cyanidin 3, 5-diglucoside |
| Category | Natural compounds |
| 2D Structure |
|
| 3D Structure | |
| Molecular Formula | C 2 7 H 3 1 O 1 6 + |
| Molecular Weight | 611.5 g/mol |
| IUPAC Name | (2S, 4S, 5S)-2-[2-(3, 4-dihydroxyphenyl)-7-hydroxy-3-[(2S, 5S)-3, 4, 5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromenylium-5-yl]oxy-6-(hydroxymethyl)oxane-3, 4, 5-triol |
| InChI | InChI=1S/C27H30O16/c28-7-17-19(33)21(35)23(37)26(42-17)40-15-5-10(30)4-14-11(15)6-16(25(39-14)9-1-2-12(31)13(32)3-9)41-27-24(38)22(36)20(34)18(8-29)43-27/h1-6, 17-24, 26-29, 33-38H, 7-8H2, (H2-, 30, 31, 32)/p+1/t17?, 18?, 19-, 20-, 21+, 22?, 23?, 24?, 26-, 27-/m1/s1 |
| InChIKey | RDFLLVCQYHQOBU-DHXMCCLBSA-O |
| Canonical SMILES | C1=CC(=C(C=C1C2=C(C=C3C(=CC(=CC3=[O+]2)O)OC4C(C(C(C(O4)CO)O)O)O)OC5C(C(C(C(O5)CO)O)O)O)O)O |
| PubChem CID | 44256718 |
| DrugBank Accession Number | - |
| CAS Registry Number | - |
| Molecular Weight(Computed by SwissADME) | 611.53 |
| Hac(Computed by SwissADME) | 43 |
| Volume(Computed by ADMETlab 2.0) | 553.636 |
| Density(Computed by ADMETlab 2.0) | 1.104 |
| nRing(Computed by ADMETlab 2.0) | 5 |
| MaxRing(Computed by ADMETlab 2.0) | 10 |
| nHet(Computed by ADMETlab 2.0) | 16 |
| fChar(Computed by ADMETlab 2.0) | 1 |
| nRig(Computed by ADMETlab 2.0) | 29 |
| Flexibility(Computed by ADMETlab 2.0) | 0.241 |
| Stero Centers(Computed by ADMETlab 2.0) | 10 |
| LogS(Computed by ADMETlab 2.0) | -2.702 |
| LogD(Computed by ADMETlab 2.0) | 0.414 |
| logP(Computed by ADMETlab 2.0) | -1.2 |
| TPSA(Computed by SwissADME) | 272.59 |
| Hbond Acceptor(Computed by SwissADME) | 16 |
| Hbond Donor(Computed by SwissADME) | 11 |
| Rotatable Bonds(Computed by SwissADME) | 7 |
| GI Absorption(Computed by SwissADME) | Low |
| BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No |
| P-gp Substrate(Computed by SwissADME) | Yes |
| CYP1A2 Inhibitor(Computed by SwissADME) | No |
| CYP2C19 Inhibitor(Computed by SwissADME) | No |
| CYP2C9 Inhibitor(Computed by SwissADME) | No |
| CYP2D6 Inhibitor(Computed by SwissADME) | No |
| CYP3A4 Inhibitor(Computed by SwissADME) | No |
| log Kp(Skin Permeation)(Computed by SwissADME) | -12.05 |
| Lipinski(Computed by SwissADME) | 3 |
| Ghose(Computed by SwissADME) | 4 |
| Veber(Computed by SwissADME) | 1 |
| Egan(Computed by SwissADME) | 1 |
| Muegge(Computed by SwissADME) | 5 |
| Bioavailability Score(Computed by SwissADME) | 0.17 |